Biotechnological Kits Market to be dominated by Technological Advancements through 2027
Growth in inherited diseases and
technological advancements will drive global biotechnological kits market in
the forecast period, 2023-2027.
According to TechSci Research
report, “Biotechnological Kits Market - Global Industry Size, Share, Trends, Opportunity,
and Forecast, 2017-2027”, the global biotechnological
kits market is anticipated to grow at a significant rate in the forecast
period, 2023-2027. The increase in inherited diseases, and demand for
technological advancements are the primary factors driving the demand for the global
biotechnological kits market. Growing technological investments by leading companies,
increase in funding of research and development (R&D) projects by
governments and wide application of biotechnological kits in various fields
such as pharmaceutical industries, food industries, agriculture and
bioinformatics are expected to influence the market demand.
However,
stringent environmental regulatory approval process for
biotechnology kits may hamper the growth of
the market in the forecast period.
Browse over XX market data Figures spread through 110 Pages and
an in-depth TOC on "Biotechnological Kits Market"
The global biotechnological kits market
is segmented into kit type, technology, parameter tested, microorganism,
purpose, end user, company. Based on the kit type, the market is bifurcated
into purification kits, amplification kits, detection kits, isolation kits, and
others. The detection kits segment is expected to hold the largest market share
in the forecast period, 2023-2027. This is attributable to the huge
consumption of detection kits in the various end use areas like healthcare,
agriculture, food and industrial processing. The requirement for the detection
kits rose in 2020, owing to the need for the COVID-19 testing across the world.
The production of the detection kits promptly increased in the healthcare
sectors due to the growing demand for the detections kits for detecting
COVID-19 nucleic acid.
Based on technology, the market is divided
into LAMP technology, PCR, cell culture, sequencing,
chromatography, electrophoresis, and others. PCR technique is likely to
hold the largest market share. This technique offers high specificity and
sensitivity, and are, thereby, considered the go-to methods for various genomic
studies such as the detection and analysis of specific gene sequences.
Based on parameter
tested, the market is divided into DNA, RNA, enzymes, proteins, and
others. the RNA segment is expected to account for a significant market
share over the forecast period. Over the past few years, various funding and
investments are done in extracellular RNA which has attributed for clinical
diagnosis. Various research and development projects are carried in
universities for RNA based therapeutic which will contribute to the growth of
this segment in upcoming years
Based on microorganism, the
market is divided into bacteria, fungi, virus, and others. The virus segment is
projected to witness the significant growth of the market share due to the increased
application of viruses in gene therapy and vaccinology. Growing research and
development activities in the use of virus as a vector in the vaccine
development is considered the main factor for the supremacy of this segment in
the market. Likewise, the COVID-19 outbreak has considerably impacted the growth
of this segment.
Based on purpose, the market is
divided into on-site and laboratory. On-site sub segment is expected
to witness a considerable growth due to increase in Point-of-Care (POC) testing.
One-site segment has wide applications in food and beverage industry. It
includes enzymatic and microbiological on-site testing.
Based on end
user, the market is divided into healthcare, food & agriculture, industrial
processing, and others. The healthcare sector is projected to grow in the
forecast period owing to extensive R&D, ongoing clinical trials, and
increased collaborations and mergers for new novel technology.
Major operating companies
operating in global biotechnological kits market are:
- Thermo Fischer Scientific, Inc.
- QIAGEN N.V., Illumina, Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche AG
- Merck KGaA
- Promega Corporation
- Takara Bio, Inc
- New England Biolabs UK Limited
Download Free Sample Report
Customers can also request for 10% free customization on this
report.
“The North America region
dominates the market in 2021 and is expected to maintain its dominance in the
coming years due to increase in inherited diseases. North America is one of the
largest countries to have well-developed healthcare amenities as well as
massive high-quality research and presence of skilled professionals. Also, the
high population rate, increasing awareness and investments on biotechnology
sector are expected to propel the global biotechnological kits market growth
till 2027” said Mr. Karan Chechi, Research Director with TechSci Research, a research
based global management consulting firm.
“Biotechnology
Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Kit Type (Purification Kits, Amplification Kits,
Detection Kits, Isolation Kits, Others), By Technology (LAMP Technology, PCR,
Cell Culture, Sequencing, Chromatography, Electrophoresis, Others), By
Parameter Tested (DNA, RNA, Enzymes, Proteins, Others), By Microorganism
(Bacteria, Fungi, Virus, Others), By Purpose (On-site v/s Laboratory), By End
User (Healthcare, Food & Agriculture, Industrial Processing, Others), By
Company, and By Region”, has evaluated the future growth potential of global biotechnological
kits and provides statistics & information on market size, structure, and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in global biotechnological
kits market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com